Results 261 to 270 of about 871,553 (293)

HIV Broadly Neutralizing Antibodies: VRC01 and Beyond

2018
Developing an effective prophylaxis HIV-1 vaccine is likely to require the elicitation of broadly neutralizing antibodies (bnAbs). As the HIV-1 envelope (Env) glycoprotein - the sole target of bnAbs - has evolved multiple mechanisms to evade antibody neutralization, the processes for bnAb generation are highly selective and time-consuming.
openaire   +2 more sources

Broadly Neutralizing Antibodies

2017
L. Morris, T.A. Moody
openaire   +1 more source

Broadly Neutralizing Antibodies and the Development of Vaccines

JAMA, 2015
Barton F, Haynes, Todd, Bradley
openaire   +2 more sources

B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies

Cell Host and Microbe, 2021
Nelson Michael, Rebecca Grande, Ningbo Jian   +2 more
exaly  

BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV

2021
SAJADI MOHAMMAD, LEWIS GEORGE K, DEVICO ANTHONY, KIM DONGKYOON, CAVET GUY   +4 more
openaire   +7 more sources

Broadly neutralizing antibodies target a haemagglutinin anchor epitope

Nature, 2022
Raffael Nachbagauer, Alba Torrents de la Peña, Olivia Stovicek   +2 more
exaly  

Broadly Neutralizing Antibodies

RCSB Protein Data Bank, 2014
openaire   +1 more source

A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations

Cell Host and Microbe, 2020
Ype Peter de Jong, Qiao Wang, Davide F. Robbiani   +2 more
exaly  

Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities

Emerging Microbes and Infections, 2020
Yubin Liu, Taisheng Li, Wei Cao
exaly  

Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller

Cell Host and Microbe, 2023
Hugo Mouquet, MONCEAUX Valérie
exaly